TXNRD1 and glioblastoma: In terms of overcoming drug resistance, glioblastoma cells can mediate TMZ resistance through thioredoxin reductase 1 (TrxR1), while the small molecule inhibitor BS1801 relieves TMZ resistance by targeting TrxR1 and increasing the level of reactive oxygen species.94